Devicemakers See Mixed Results in Second Quarter Earnings

Devices & Diagnostics Letter
A A
Boston Scientific saw sales for its implantable cardioverter defibrillators (ICD) bounce back after a monthlong shipment hold and vows from physicians to switch to other devices.

To View This Article:

Login

Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $10.00